Transgluteal MRI in-bore prostate biopsy in routine clinical practice: a contemporary-cohort-study from a german tertiary center
MRI-guided prostate biopsy enables accurate detection of clinically significant prostate cancer with low risk of understaging, supporting its routine use in personalized urologic oncology.
Authors
- Mike Wenzel (ORCID: https://orcid.org/0000-0002-4338-0889)
- P. Mandel
- Scherwin Mahmoudi (ORCID: https://orcid.org/0000-0002-4020-1873)
- Jens W. Köllermann (ORCID: https://orcid.org/0000-0001-8495-6621)
- Boris Bodelle (ORCID: https://orcid.org/0000-0002-2409-0528)
- Jennifer Gotta (ORCID: https://orcid.org/0000-0002-0524-6574)
- Simon Bernatz (ORCID: https://orcid.org/0000-0002-7758-8100)
- PJ Wild
- Katrin Eichler
- Benedikt Hoeh (ORCID: https://orcid.org/0000-0002-4238-6584)
- Simon S. Martin (ORCID: https://orcid.org/0000-0003-3347-4520)
- Philipp Reschke (ORCID: https://orcid.org/0009-0006-9123-7581)
- Maximilian Holzer
- Leon D. Grünewald
- Jan-Erik Scholtz
- Felix Chun
- Renate Hammerstingl
- Vitali Koch
- Thomas J. Vogl
- Tatjana Gruber-Rouh
Institutions
- Goethe University Frankfurt (DE)
- Frankfurt Institute for Advanced Studies (DE)
- Klinikum Mutterhaus der Borromäerinnen (DE)
- University Hospital Frankfurt (DE)
- University Hospital Carl Gustav Carus (DE)
- Technische Universität Dresden (DE)
Publication Details
- Journal
- International Urology and Nephrology
- Published
- 2026-01-02
- DOI
- https://doi.org/10.1007/s11255-025-04983-4
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00